Skip to main content

Stonepine Capital Management, LLC

13F filer · CIK 0001440771
Reported Aug 17, 2026
Net buyer this quarter
13F portfolio value$177MU.S. long equity reported on 13F
Positions7218 new · 12 closed
Net flow last quarter+$9.79MBuys minus sells
Top 10 positions weight40.9%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 17, 202672 positions
VSTMVerastem, Inc.$12.8M7.22%3.70%+1.4%Q4 2017
EOLSEvolus, Inc.$11M6.23%2.41%-9.6%Q1 2018
TENXTenax Therapeutics, Inc.$9.6M5.42%2.07%-32.3%Q3 2024
NKTRNektar Therapeutics$8.42M4.75%0.59%+42.0%Q1 2024
ADMAAdma Biologics, Inc.$6.19M3.49%0.33%Not reportedQ4 2017
CAMPCamp4 Therapeutics Corp$6.07M3.43%2.68%Not reportedQ4 2025
ELOXEloxx Pharmaceuticals, Inc.$5.51M3.11%9.84%NewQ2 2026
KZIAKazia Therapeutics Ltd$4.86M2.74%0.04%Not reportedQ4 2025
INDVIndivior Pharmaceuticals, Inc.$4.1M2.31%0.08%Not reportedQ3 2024
CRBPCorbus Pharmaceuticals Holdings, Inc.$3.99M2.25%2.28%+10.8%Q1 2025
MSLESatellos Bioscience Inc.$3.72M2.10%38.16%+391.6%Q1 2026
ZVRAZevra Therapeutics, Inc.$3.71M2.09%0.44%-46.1%Q3 2024
ABEOAbeona Therapeutics Inc.$3.44M1.94%0.97%-25.4%Q2 2025
EDSAEdesa Biotech, Inc.$3.19M1.80%4.74%+1421.5%Q1 2025
CABACabaletta Bio, Inc.$2.85M1.61%0.56%+1734.2%Q4 2025
ANTXAN2 Therapeutics, Inc.$2.67M1.51%1.52%-22.7%Q4 2024
XLOXilio Therapeutics, Inc.$2.17M1.22%3.43%+252.2%Q4 2025
ACETAdicet Bio, Inc.$2.12M1.20%2.62%+10.6%Q1 2024
TELATELA Bio, Inc.$2M1.13%5.94%+1.7%Q2 2023
AYTUAytu Biopharma, Inc$1.96M1.11%8.51%+15.2%Q4 2020
CRISCuris Inc$1.73M0.98%169.94%-11.1%Q4 2025
SPRBSpruce Biosciences, Inc.$1.55M0.88%1.05%Not reportedQ4 2025
OKYOOKYO Pharma Ltd$1.29M0.73%2.29%+1.5%Q1 2026
KTTAPasithea Therapeutics Corp.$1.13M0.64%6.59%+164.8%Q4 2025
SLGLSol-Gel Technologies Ltd.$1.07M0.61%0.52%-47.9%Q1 2026
LUNGPulmonx Corp$1.06M0.60%1.90%+6.1%Q2 2025
XFORX4 Pharmaceuticals, Inc$1.05M0.59%0.23%-32.9%Q2 2023
INABIn8bio, Inc.$980K0.55%7.06%+4.8%Q2 2025
MLTXMoonLake Immunotherapeutics$974K0.55%0.07%NewQ2 2026
QNRXQuoin Pharmaceuticals, Ltd.$966K0.54%0.28%+273.2%Q4 2025
MXCTMaxcyte, Inc.$924K0.52%0.71%-25.2%Q4 2022
PHATPhathom Pharmaceuticals, Inc.$922K0.52%0.11%+70.0%Q1 2026
AZTRAzitra, Inc.$887K0.50%8.72%NewQ2 2026
CNTBConnect Biopharma Holdings Ltd$867K0.49%0.58%+17.5%Q1 2026
HELPCybin Inc.$855K0.48%0.25%-3.6%Q4 2025
RAREUltragenyx Pharmaceutical Inc.$835K0.47%0.03%Not reportedQ3 2025
IKTInhibikase Therapeutics, Inc.$804K0.45%0.30%-58.6%Q4 2024
ZNTLZentalis Pharmaceuticals, Inc.$784K0.44%0.23%-40.0%Q1 2025
CTMXCytomX Therapeutics, Inc.$769K0.43%0.09%+2.5%Q3 2025
NVCTNuvectis Pharma, Inc.$736K0.41%0.15%NewQ2 2026
CBIOCrescent Biopharma, Inc.$720K0.41%0.14%-52.9%Q4 2025
PMVPPMV Pharmaceuticals, Inc.$718K0.41%1.00%-24.3%Q4 2024
ORKAOruka Therapeutics, Inc.$714K0.40%0.01%NewQ2 2026
RADXRadiopharm Theranostics Ltd$671K0.38%2.16%Not reportedQ4 2025
OKUROnKure Therapeutics, Inc.$596K0.34%0.32%-1.4%Q1 2026
NGENNervgen Pharma Corp.$560K0.32%0.34%NewQ2 2026
CALCCalciMedica, Inc.$545K0.31%2.03%Not reportedQ1 2024
ARVNArvinas, Inc.$499K0.28%0.09%+118.2%Q1 2026
BIOABioAge Labs, Inc.$490K0.28%0.04%-60.0%Q1 2025
IRDOpus Genetics, Inc.$414K0.23%0.12%+46.6%Q1 2026
Q1 2026Reported May 14, 202666 positions
VSTMVerastem, Inc.$17.5M7.01%3.76%+20.9%Q4 2017
TENXTenax Therapeutics, Inc.$15.6M6.24%4.02%+8106.0%Q3 2024
EOLSEvolus, Inc.$7.23M2.90%2.67%+7.8%Q1 2018
ADMAAdma Biologics, Inc.$6.67M2.67%0.32%Not reportedQ4 2017
CAMPCamp4 Therapeutics Corp$6.13M2.45%2.68%+507.1%Q4 2025
NKTRNektar Therapeutics$6.12M2.45%0.42%Not reportedQ1 2024
ZVRAZevra Therapeutics, Inc.$4.47M1.79%0.81%-15.7%Q3 2024
CRBPCorbus Pharmaceuticals Holdings, Inc.$3.6M1.44%2.16%-1.7%Q1 2025
ABEOAbeona Therapeutics Inc.$3.34M1.34%1.31%+5.2%Q2 2025
KZIAKazia Therapeutics Ltd$2.57M1.03%0.04%-25.0%Q4 2025
ANTXAN2 Therapeutics, Inc.$2.44M0.98%1.98%+13.7%Q4 2024
SLGLSol-Gel Technologies Ltd.$2.2M0.88%1.00%NewQ1 2026
XOMAXOMA Royalty Corp$2.18M0.87%0.58%-39.6%Q1 2017
AYTUAytu Biopharma, Inc$2.16M0.87%7.38%-2.6%Q4 2020
CRISCuris Inc$2.04M0.82%9.32%+6178.8%Q4 2025
TELATELA Bio, Inc.$1.62M0.65%5.85%+11.3%Q2 2023
IKTInhibikase Therapeutics, Inc.$1.61M0.64%0.73%-59.2%Q4 2024
CBIOCrescent Biopharma, Inc.$1.56M0.63%0.31%-3.1%Q4 2025
ACETAdicet Bio, Inc.$1.51M0.61%2.31%+0.9%Q1 2024
XFORX4 Pharmaceuticals, Inc$1.38M0.55%0.36%-43.5%Q2 2023
OKYOOKYO Pharma Ltd$1.37M0.55%2.26%NewQ1 2026
HRTXHeron Therapeutics, Inc.$1.12M0.45%0.74%+13.3%Q4 2024
LUNGPulmonx Corp$991K0.40%1.82%+58.0%Q2 2025
INABIn8bio, Inc.$982K0.39%6.74%+302.3%Q2 2025
SRZNSurrozen, Inc.$961K0.39%0.29%-71.0%Q2 2024
CTMXCytomX Therapeutics, Inc.$940K0.38%0.12%Not reportedQ3 2025
PMVPPMV Pharmaceuticals, Inc.$878K0.35%1.33%-38.5%Q4 2024
BIOABioAge Labs, Inc.$875K0.35%0.11%+11.1%Q1 2025
CNTBConnect Biopharma Holdings Ltd$812K0.33%0.49%NewQ1 2026
RADXRadiopharm Theranostics Ltd$739K0.30%2.16%Not reportedQ4 2025
MXCTMaxcyte, Inc.$706K0.28%0.94%+114.2%Q4 2022
CDXSCodexis, Inc.$681K0.27%0.46%+63.2%Q3 2025
BOLDBoundless Bio, Inc.$657K0.26%2.67%-15.8%Q2 2025
HELPCybin Inc.$643K0.26%0.26%-60.6%Q4 2025
ZNTLZentalis Pharmaceuticals, Inc.$630K0.25%0.38%-42.0%Q1 2025
KTTAPasithea Therapeutics Corp.$617K0.25%3.33%+202.2%Q4 2025
MSLESatellos Bioscience Inc.$563K0.23%7.76%NewQ1 2026
PHATPhathom Pharmaceuticals, Inc.$556K0.22%0.06%NewQ1 2026
OKUROnKure Therapeutics, Inc.$549K0.22%0.97%NewQ1 2026
XLOXilio Therapeutics, Inc.$540K0.22%1.11%+611.4%Q4 2025
VRCAVerrica Pharmaceuticals Inc.$528K0.21%0.58%-71.8%Q4 2025
CADLCandel Therapeutics, Inc.$502K0.20%0.14%NewQ1 2026
POCIPrecision Optics Corporation, Inc.$439K0.18%0.91%NewQ1 2026
QNRXQuoin Pharmaceuticals, Ltd.$353K0.14%0.08%-31.6%Q4 2025
ESTAEstablishment Labs Holdings Inc.$341K0.14%0.02%Not reportedQ3 2024
UPBUpstream Bio, Inc.$315K0.13%0.06%NewQ1 2026
IRDOpus Genetics, Inc.$313K0.13%0.10%NewQ1 2026
ARVNArvinas, Inc.$292K0.12%0.04%NewQ1 2026
PLRXPliant Therapeutics, Inc.$283K0.11%0.36%-2.4%Q3 2025
JANXJanux Therapeutics, Inc.$278K0.11%0.03%Not reportedQ4 2025
Q4 2025Reported Feb 13, 202661 positions
VSTMVerastem, Inc.$21.1M15.40%3.51%+2.3%Q4 2017
ADMAAdma Biologics, Inc.$13.5M9.85%0.31%+0.1%Q4 2017
EOLSEvolus, Inc.$10.9M7.92%2.51%+6.2%Q1 2018
ZVRAZevra Therapeutics, Inc.$5.1M3.72%1.00%-29.7%Q3 2024
IKTInhibikase Therapeutics, Inc.$4.81M3.51%1.78%+219.5%Q4 2024
ABEOAbeona Therapeutics Inc.$3.74M2.73%1.29%+57.3%Q2 2025
NKTRNektar Therapeutics$3.59M2.62%0.42%Not reportedQ1 2024
INDVIndivior Pharmaceuticals, Inc.$3.59M2.62%0.08%Not reportedQ3 2024
CRBPCorbus Pharmaceuticals Holdings, Inc.$3.17M2.32%2.21%Not reportedQ1 2025
KZIAKazia Therapeutics Ltd$3.17M2.32%0.06%NewQ4 2025
XOMAXOMA Royalty Corp$3.06M2.23%0.97%-0.4%Q1 2017
VRCAVerrica Pharmaceuticals Inc.$2.94M2.15%2.06%NewQ4 2025
HELPCybin Inc.$2.78M2.03%1.57%NewQ4 2025
TELATELA Bio, Inc.$2.78M2.03%5.28%+9.1%Q2 2023
ACADAcadia Pharmaceuticals Inc$2.67M1.95%0.06%-42.7%Q2 2018
SRZNSurrozen, Inc.$2.57M1.87%1.16%-54.6%Q2 2024
XFORX4 Pharmaceuticals, Inc$2.37M1.73%0.65%-43.8%Q2 2023
AYTUAytu Biopharma, Inc$2.12M1.54%7.58%-8.8%Q4 2020
DAWNDay One Biopharmaceuticals, Inc.$1.86M1.36%0.19%-69.1%Q3 2024
ACETAdicet Bio, Inc.$1.85M1.35%2.29%Not reportedQ1 2024
SPRBSpruce Biosciences, Inc.$1.72M1.26%1.44%NewQ4 2025
HRTXHeron Therapeutics, Inc.$1.61M1.17%0.66%+45.6%Q4 2024
ENTAEnanta Pharmaceuticals Inc$1.58M1.15%0.34%-67.2%Q4 2015
PMVPPMV Pharmaceuticals, Inc.$1.44M1.05%2.16%-16.0%Q4 2024
CAMPCamp4 Therapeutics Corp$1.4M1.02%0.44%NewQ4 2025
ELDNEledon Pharmaceuticals, Inc.$1.35M0.98%1.18%NewQ4 2025
MISTMilestone Pharmaceuticals Inc.$1.34M0.98%0.62%Not reportedQ1 2024
OABIOmniAb, Inc.$1.3M0.95%0.49%-67.3%Q4 2022
QNRXQuoin Pharmaceuticals, Ltd.$1.13M0.82%0.15%NewQ4 2025
LUNGPulmonx Corp$1.07M0.78%1.17%-27.4%Q2 2025
GERNGeron Corp$1.06M0.78%0.13%-49.6%Q1 2025
CBIOCrescent Biopharma, Inc.$1.04M0.76%0.32%NewQ4 2025
KZRKezar Life Sciences, Inc.$982K0.72%2.13%-59.2%Q2 2024
EDSAEdesa Biotech, Inc.$976K0.71%8.25%Not reportedQ1 2025
BOLDBoundless Bio, Inc.$852K0.62%3.17%+71.7%Q2 2025
RADXRadiopharm Theranostics Ltd$851K0.62%2.16%NewQ4 2025
SMLRSemler Scientific, Inc.$765K0.56%0.33%NewQ4 2025
MXCTMaxcyte, Inc.$727K0.53%0.44%+2.2%Q4 2022
ANTXAN2 Therapeutics, Inc.$716K0.52%2.29%+11.3%Q4 2024
GOSSGossamer Bio, Inc.$635K0.46%0.09%Not reportedQ3 2023
ZNTLZentalis Pharmaceuticals, Inc.$626K0.46%0.67%+2.2%Q1 2025
BIOABioAge Labs, Inc.$595K0.43%0.12%-76.1%Q1 2025
MNKDMannkind Corp$490K0.36%0.03%-45.2%Q3 2025
CGENCompugen Ltd$467K0.34%0.32%NewQ4 2025
CDXSCodexis, Inc.$417K0.30%0.28%+190.2%Q3 2025
INABIn8bio, Inc.$386K0.28%1.69%+3.4%Q2 2025
FENCFennec Pharmaceuticals Inc.$385K0.28%0.15%NewQ4 2025
CABACabaletta Bio, Inc.$375K0.27%0.17%NewQ4 2025
KTTAPasithea Therapeutics Corp.$355K0.26%1.19%NewQ4 2025
PLRXPliant Therapeutics, Inc.$281K0.20%0.37%-20.5%Q3 2025
Q3 2025Reported Nov 13, 202558 positions
VSTMVerastem, Inc.$23.6M19.17%4.00%+96.3%Q4 2017
ADMAAdma Biologics, Inc.$10.8M8.81%0.31%-1.5%Q4 2017
EOLSEvolus, Inc.$9.43M7.67%2.37%+67.6%Q1 2018
ZVRAZevra Therapeutics, Inc.$7.7M6.26%1.44%+4.4%Q3 2024
NKTRNektar Therapeutics$4.84M3.93%0.43%+69.3%Q1 2024
DAWNDay One Biopharmaceuticals, Inc.$4.56M3.71%0.63%+43.9%Q3 2024
XOMAXOMA Royalty Corp$4.45M3.62%0.94%-24.1%Q1 2017
ACADAcadia Pharmaceuticals Inc$3.72M3.03%0.10%-22.4%Q2 2018
ENTAEnanta Pharmaceuticals Inc$3.65M2.97%1.43%-49.5%Q4 2015
XFORX4 Pharmaceuticals, Inc$3.61M2.94%4.20%Not reportedQ2 2023
OABIOmniAb, Inc.$3.43M2.79%1.49%Not reportedQ4 2022
SRZNSurrozen, Inc.$3.22M2.62%2.92%-18.3%Q2 2024
TELATELA Bio, Inc.$3.21M2.61%5.34%+3.4%Q2 2023
INDVIndivior Pharmaceuticals, Inc.$2.41M1.96%0.08%-71.4%Q3 2024
ABEOAbeona Therapeutics Inc.$2.38M1.94%0.86%+902.2%Q2 2025
GERNGeron Corp$2.19M1.78%0.25%+60.0%Q1 2025
PMVPPMV Pharmaceuticals, Inc.$1.92M1.56%2.59%+62.0%Q4 2024
EDSAEdesa Biotech, Inc.$1.7M1.38%9.63%Not reportedQ1 2025
AYTUAytu Biopharma, Inc$1.68M1.36%9.00%+9.7%Q4 2020
SLNOSoleno Therapeutics Inc$1.62M1.32%0.04%NewQ3 2025
KZRKezar Life Sciences, Inc.$1.49M1.21%5.23%+125.6%Q2 2024
ALMSAlumis Inc.$1.2M0.97%Not reported-14.2%Q2 2025
IKTInhibikase Therapeutics, Inc.$1.19M0.97%0.98%+0.2%Q4 2024
BIOABioAge Labs, Inc.$1.11M0.90%0.53%+24.8%Q1 2025
ARDXArdelyx, Inc.$1.1M0.90%0.08%-64.0%Q2 2025
LUNGPulmonx Corp$1.09M0.88%1.62%+359.2%Q2 2025
DVAXDynavax Technologies Corp$1.07M0.87%0.09%+260.3%Q1 2023
HRTXHeron Therapeutics, Inc.$1.07M0.87%0.55%+29.3%Q4 2024
VNDAVanda Pharmaceuticals Inc.$973K0.79%0.33%-22.0%Q4 2015
VIRVir Biotechnology, Inc.$914K0.74%0.12%+23.1%Q4 2024
MNKDMannkind Corp$846K0.69%0.05%NewQ3 2025
MXCTMaxcyte, Inc.$725K0.59%0.43%Not reportedQ4 2022
ANTXAN2 Therapeutics, Inc.$716K0.58%2.06%+3.6%Q4 2024
ZNTLZentalis Pharmaceuticals, Inc.$685K0.56%0.63%+316.3%Q1 2025
ANGOAngiodynamics Inc$670K0.54%0.14%-22.2%Q2 2025
GRCEGrace Therapeutics, Inc.$628K0.51%1.49%-27.9%Q1 2025
RAREUltragenyx Pharmaceutical Inc.$602K0.49%0.02%NewQ3 2025
SNDXSyndax Pharmaceuticals Inc$572K0.47%0.04%-60.0%Q2 2018
AQSTAquestive Therapeutics, Inc.$562K0.46%0.08%Not reportedQ4 2024
GOSSGossamer Bio, Inc.$539K0.44%0.09%Not reportedQ3 2023
BOLDBoundless Bio, Inc.$509K0.41%1.85%+289.4%Q2 2025
HCATHealth Catalyst, Inc.$443K0.36%0.22%+55.6%Q2 2025
ESTAEstablishment Labs Holdings Inc.$434K0.35%0.04%+51.2%Q3 2024
PLRXPliant Therapeutics, Inc.$428K0.35%0.47%NewQ3 2025
CTMXCytomX Therapeutics, Inc.$399K0.32%0.08%NewQ3 2025
KPRXKiora Pharmaceuticals Inc$391K0.32%4.09%-21.0%Q2 2024
RZLTRezolute, Inc.$376K0.31%0.04%-81.7%Q4 2021
ACRSAclaris Therapeutics, Inc.$367K0.30%0.18%-60.7%Q2 2024
INABIn8bio, Inc.$346K0.28%3.47%+93.4%Q2 2025
HSDTSolana Co$298K0.24%0.05%NewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.